title: The impact of linezolid and vancomycin treatment on local signs and symptoms of inflammation among pediatric patients with complicated skin and skin structure infections.
authors.affiliation: University of California at Los Angeles, Los Angeles, CA, USA.
authors.forename: Jaime G
authors.initials: JG
authors.lastname: Deville
authors.forename: Ozlem
authors.initials: O
authors.lastname: Equils
authors.forename: David B
authors.initials: DB
authors.lastname: Huang
authors.forename: Jocelyn Y
authors.initials: JY
authors.lastname: Ang
mesh_terms: D000081:Acetamides / Q000008:administration & dosage / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D006760:Hospitalization; D006801:Humans; D007223:Infant; D000069349:Linezolid; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects* / Q000472:pathogenicity; D023303:Oxazolidinones / Q000008:administration & dosage / Q000627:therapeutic use*; D010372:Pediatrics / Q000379:methods; D017192:Skin Diseases, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D016896:Treatment Outcome; D014640:Vancomycin / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D014640:Vancomycin; D000069349:Linezolid